Ceapro Inc.
CRPOFOTCHealthcare
$0.17
$-0.03(-13.04%)
Market Cap$13309844
P/E Ratio—
52W High$0.399
52W Low$0.115
Ceapro Inc. (CRPOF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CRPOF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2024Report Date: Apr 29, 2024EPS Actual
-$0.02
Revenue
$0.00B
Fiscal Period
Q2 FY2024
FY ends December
Report Date
Apr 29, 2024
After Market Close
CRPOF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2024 | Apr 29, 2024 | — | -$0.02 | — | $0.00B | — | — |
| — Q1 FY2024 | Feb 27, 2024 | — | -$0.02 | — | $0.00B | — | — |
| — Q4 FY2023 | Nov 29, 2023 | — | -$0.01 | — | $0.00B | — | — |
| — Q3 FY2023 | Aug 29, 2023 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2023 | May 25, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2023 | Apr 12, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2022 | Nov 9, 2022 | — | $0.01 | — | $0.00B | — | — |
| — Q3 FY2022 | Aug 24, 2022 | — | $0.02 | — | $0.00B | — | — |
Q2 FY2024
Apr 29, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2024
Feb 27, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Nov 29, 2023
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2023
Aug 29, 2023
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
May 25, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Apr 12, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Nov 9, 2022
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Aug 24, 2022
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2024 | Apr 29, 2024 | — | $7.82 | — | — |
| — Q1 FY2024 | Feb 27, 2024 | — | $6.63 | $6.57 | -0.90% |
| — Q4 FY2023 | Nov 29, 2023 | — | $8.04 | $7.80 | -2.99% |
| — Q3 FY2023 | Aug 29, 2023 | — | $14.41 | $12.47 | -13.46% |
| — Q2 FY2023 | May 25, 2023 | — | $17.06 | $13.43 | -21.28% |
| — Q2 FY2023 | Apr 12, 2023 | — | $19.07 | $19.07 | +0.00% |
| — Q4 FY2022 | Nov 9, 2022 | — | $24.93 | $24.92 | -0.04% |
| — Q3 FY2022 | Aug 24, 2022 | — | $23.47 | $24.29 | +3.49% |
Q2 FY2024—
Report Date
Apr 29, 2024
EPS Beat/Miss
—
Price Before
$7.82
Price After
—
Q1 FY2024-0.90%
Report Date
Feb 27, 2024
EPS Beat/Miss
—
Price Before
$6.63
Price After
$6.57
Q4 FY2023-2.99%
Report Date
Nov 29, 2023
EPS Beat/Miss
—
Price Before
$8.04
Price After
$7.80
Q3 FY2023-13.46%
Report Date
Aug 29, 2023
EPS Beat/Miss
—
Price Before
$14.41
Price After
$12.47
Q2 FY2023-21.28%
Report Date
May 25, 2023
EPS Beat/Miss
—
Price Before
$17.06
Price After
$13.43
Q2 FY2023+0.00%
Report Date
Apr 12, 2023
EPS Beat/Miss
—
Price Before
$19.07
Price After
$19.07
Q4 FY2022-0.04%
Report Date
Nov 9, 2022
EPS Beat/Miss
—
Price Before
$24.93
Price After
$24.92
Q3 FY2022+3.49%
Report Date
Aug 24, 2022
EPS Beat/Miss
—
Price Before
$23.47
Price After
$24.29
Beat Rate0 / 8 quarters
Largest Move-21.28% (Q2 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CRPOF ends December
Ceapro Inc. (CRPOF) most recently reported earnings on April 29, 2024 for Q2 FY2024, posting EPS of $-0.02 (in line with the analyst consensus of —). The next CRPOF earnings date is expected around September 1, 2026.
Each quarter, investors track CRPOF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CRPOF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CRPOF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CRPOF earnings · 4 questionsCeapro Inc.'s next earnings report is expected around September 1, 2026. CRPOF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CRPOF historically reports after market close (AMC).
CRPOF earnings datewhen is CRPOF earningsCRPOF next earnings datewhen does CRPOF report earningsCRPOF earnings calendar
▸ Source: FMP · Ceapro Inc. SEC filings · US GAAP · Ceapro Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026